Prognostic significance of multiple kallikreins in high-grade astrocytoma

被引:0
作者
Kristen L. Drucker
Caterina Gianinni
Paul A. Decker
Eleftherios P. Diamandis
Isobel A. Scarisbrick
机构
[1] Mayo Clinic Rochester,Department of Physical Medicine and Rehabilitation, Mayo Medical and Graduate School
[2] Mayo Clinic Rochester,Department of Laboratory Medicine and Pathology, Mayo Medical and Graduate School
[3] Mayo Clinic Rochester,Biomedical Statistics and Informatics, Mayo Medical and Graduate School
[4] Mount Sinai Hospital,Department of Pathology and Laboratory Medicine
[5] Mayo Clinic Rochester,Department of Physiology and Biomedical Engineering, Mayo Medical and Graduate School
来源
BMC Cancer | / 15卷
关键词
Glioblastoma; Kallikrein; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 264 条
  • [1] Emami N(2008)Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers Clin Chem 54 1600-7
  • [2] Diamandis EP(2006)The kallikrein world: an update on the human tissue kallikreins Biol Chem 387 643-52
  • [3] Paliouras M(2011)Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas Mol Oncol 5 48-60
  • [4] Diamandis EP(2012)Risk-based prostate cancer screening Eur Urol 61 652-61
  • [5] Bayani J(2013)Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma Neuro Oncol 15 305-18
  • [6] Marrano P(1999)Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene 18 4144-52
  • [7] Graham C(2000)Loss of heterozygosity on chromosome 19 in secondary glioblastomas J Neuropathol Exp Neurol 59 539-43
  • [8] Zheng Y(2006)A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma Cancer Res 66 9852-61
  • [9] Li L(2000)Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers Genes Chromosomes Cancer 29 16-25
  • [10] Katsaros D(2005)The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years Cancer 104 825-32